- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| UNIVERSAL IBOGAINE Aktie jetzt für 0€ handeln | |||||
| 03.02. | Universal Ibogaine Inc: Universal Ibogaine suspended by ASC | 19 | Stockwatch | ||
| 03.02. | XFRA JC4: AUSSETZUNG/SUSPENSION | 124 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILUNIVERSAL IBOGAINE... ► Artikel lesen | |
| 20.01. | Universal Ibogaine Inc: Universal Ibogaine has no material changes | 28 | Stockwatch | ||
| 19.01. | Universal Ibogaine Inc.: Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process | 6 | TheNewswire | ||
| 03.01. | Universal Ibogaine Inc: Universal Ibogaine debt matures; MCTO in effect | 10 | Stockwatch | ||
| 03.01. | Universal Ibogaine Inc.: Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process | 2 | TheNewswire | ||
| 19.12.25 | Universal Ibogaine Inc.: Universal Ibogaine Provides Bi-weekly Default Status Report on 2025 Year-end Filings and Update on Restructuring Process | 5 | TheNewswire | ||
| 03.12.25 | Universal Ibogaine Inc.: Universal Ibogaine advises further on application for Management Cease Trade Order | 8 | TheNewswire | ||
| 26.11.25 | Universal Ibogaine Inc: Universal Ibogaine applies for MCTO | 8 | Stockwatch | ||
| 25.11.25 | Universal Ibogaine Inc.: Universal Ibogaine Advises of Filing Application for Management Cease Trade Order | 4 | TheNewswire | ||
| 28.10.25 | Universal Ibogaine Inc: Universal Ibogaine "temporarily" closes Kelburn | 19 | Stockwatch | ||
| 28.10.25 | Universal Ibogaine Inc.: Universal Ibogaine Provides Corporate Update | 11 | TheNewswire | ||
| 24.09.25 | Universal Ibogaine Inc: Universal Ibogaine board lists five directors | 32 | Stockwatch | ||
| 23.09.25 | Universal Ibogaine Inc.: Universal Ibogaine Announces Board Changes | 11 | TheNewswire | ||
| 15.09.25 | Universal Ibogaine Inc: Universal Ibogaine shareholders vote down two matters | 4 | Stockwatch | ||
| 15.09.25 | Universal Ibogaine Inc.: Universal Ibogaine Announces Results of the Annual Meeting of Shareholders | 15 | TheNewswire | ||
| 05.09.25 | Universal Ibogaine Inc. provides update on intent to file Clinical Trial Application with Health Canada and confirms securing of Ibogaine drug supply | 17 | TheNewswire | ||
| 04.09.25 | Universal Ibogaine Inc: Universal Ibogaine adds Killebrew, Wagner as directors | 14 | Stockwatch | ||
| 10.04.25 | XFRA JC4: WIEDERAUFNAHME/RESUMPTION | 398 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SANOFI | 79,87 | -2,02 % | Regeneron und Sanofi erhalten Empfehlung für erweiterte Dupixent-Zulassung | DJ Regeneron und Sanofi erhalten Empfehlung für erweiterte Dupixent-Zulassung
Von Colin Kellaher
DOW JONES--Der Ausschuss für Humanarzneimittel (CHMP) der Europäischen Arzneimittel-Agentur... ► Artikel lesen | |
| CANOPY GROWTH | 0,908 | -2,26 % | Is It Time to Dump Your Shares of Canopy Growth?? | ||
| ASTRAZENECA | 171,55 | -1,61 % | UBS stuft ASTRAZENECA auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für Astrazeneca von 16300 auf 17600 Pence angehoben und die Einstufung auf "Buy" belassen. Astrazeneca stehe zum Ende dieses Jahrzehnts... ► Artikel lesen | |
| INNOCAN PHARMA | 3,880 | -6,73 % | Innocan Pharma Corporation: FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time | HERZLIYA, Israel and CALGARY, AB, Feb. 27, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"),... ► Artikel lesen | |
| ZOETIS | 108,40 | -1,72 % | Zoetis Inc. to Acquire Animal Genomics Business from Neogen, Accelerating Precision Animal Health Innovation | Acquisition strengthens Zoetis' leadership in Precision Animal Health by integrating Neogen's global genomics capabilities, expanding predictive insights and individualized care worldwide
PARSIPPANY... ► Artikel lesen | |
| IONIS PHARMACEUTICALS | 69,50 | -0,88 % | Ionis Pharmaceuticals: Einblicke in die Wachstumsstrategie auf der TD Cowen Konferenz | ||
| HAPPY BELLY FOOD GROUP | 1,080 | +0,93 % | Happy Belly Food Group Inc.: Happy Belly Food Group Announces Closing of the Sale of Holy Crap Foods as it Focuses on Accelerating its QSR Businesses | Toronto, Ontario--(Newsfile Corp. - February 27, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food... ► Artikel lesen | |
| CSPC PHARMA | 1,029 | -3,02 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - PACLITAXEL PROTEIN-BOUND PARTICLES FOR INJECTABLE SUSPENSION, RAPID SUSPENSION (ALBUMIN-BOUND) (SYHX2011G1) ... | ||
| ALTIMMUNE | 3,526 | -0,82 % | Forget Altimmune: This Proven Obesity-Drug Giant Is the Better Weight-Loss Play | ||
| CATALYST PHARMACEUTICALS | 20,400 | -0,15 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance | Full Year 2025 Total Revenues of $589.0 Million, Representing 19.8% Year-Over-Year Growth and Marking Another Year of Record Total Revenues Q4 2025 Total Revenues of $152.6 Million, Fueled by 18.3%... ► Artikel lesen | |
| NUMINUS WELLNESS | 0,027 | -100,00 % | Numinus Wellness Inc.: Numinus Wellness Provides Corporate Update | Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative... ► Artikel lesen | |
| ELANCO ANIMAL HEALTH | 21,805 | -2,24 % | Oil-Dri Corporation Of America: Amlan International and Elanco Collaborate on Japanese Educational Seminars Focused on Calf Health | CHICAGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Amlan International, the animal health business of Oil-Dri Corporation of America (NYSE: ODC), will collaborate with Elanco Animal Health on a three-day educational... ► Artikel lesen | |
| ONO PHARMACEUTICAL | 13,800 | +0,73 % | Ono Pharmaceutical Co. Ltd. Reveals Climb In Nine Months Bottom Line | TOKYO (dpa-AFX) - Ono Pharmaceutical Co. Ltd. (OPHLF) released a profit for its nine months that Increases, from the same period last yearThe company's earnings came in at JPY68.949 billion... ► Artikel lesen | |
| IANTHUS CAPITAL | 0,001 | 0,00 % | iAnthus Capital Holdings, Inc.: iAnthus Provides Update on Planned Florida Expansion, New Brand Launches, and New Jersey Bridge Notes | NEW YORK and TORONTO, Feb. 17, 2026 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN, OTCID: ITHUF), which owns, operates and partners with regulated cannabis... ► Artikel lesen | |
| TERRASCEND | 0,550 | +3,77 % | TerrAscend Reports Third Quarter 2025 Financial Results | Net Revenue of $65.1 million Gross Profit Margin of 52.1% from continuing operations, up 110 basis points from 51.0% in the third quarter of 2024 Net Cash provided from continuing operations of $7.1... ► Artikel lesen |
Das Unternehmen UNIVERSAL IBOGAINE INC kann der Branche Pharma zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,005 (-100,00 %) liegt der Kurs bei 0,005 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu UNIVERSAL IBOGAINE INC finden Sie auf Wallstreet Online.